Pretreatment 18F-FDG retention index as a predictor of histologic response after neoadjuvant chemotherapy: Preliminary results in osteosarcoma

被引：0
|
作者：
Byun, Byung Hyun [1 ]
Kong, Chang-Bae [2 ]
Lim, Ilhan [1 ]
Kim, Byung Il [1 ]
Choi, Chang Woon [1 ]
Lim, Sang Moo [1 ]
机构：
[1] Korea Canc Ctr Hosp, Dept Nucl Med, Seoul, South Korea
[2] Korea Canc Ctr Hosp, Dept Orthoped Surg, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1678
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Relevance of Breast Cancer Subtypes in Response Monitoring with 18F-FDG PET/CT During Neoadjuvant Chemotherapy
    Koolen, B. B.
    Pengel, K. E.
    Wesseling, J.
    Vogel, W. V.
    Peeters, M. Vrancken
    Gilhuijs, K. G.
    Rodenhuis, S.
    Rutgers, E. J.
    Olmos, R. A. Valdes
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S42 - S42
  • [42] Response assessment of gastric cancer to neoadjuvant chemotherapy using a modified 18F-FDG PET/CT protocol
    Wu, Chenxi
    Li, Xiaoyi
    Shi, Ximin
    Dang, Yonghong
    Hu, Nan
    Zhu, Zhaohui
    Li, Fang
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [43] On the usefulness of the 18F-FDG PET radiome of triple negative breast tumor to predict response to neoadjuvant chemotherapy
    Boughdad, Sarah
    Orlhac, Fanny
    Nioche, Christophe
    Dirand, Anne-Sophie
    Champion, Laurence
    Buvat, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [44] Predictive Value of 18F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer
    Ko, Woo Seog
    Kim, Seong-Jang
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : 574 - 580
  • [45] MRI and 18F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?
    Evangelista, Laura
    Ruggieri, Domenico
    Pescarini, Luigi
    Saladini, Giorgio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (08) : 1511 - 1514
  • [46] 18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy
    Diwanji, Devan
    Onishi, Natsuko
    Hathi, Deep K.
    Lawhn-Heath, Courtney
    Kornak, John
    Li, Wen
    Guo, Ruby
    Molina-Vega, Julissa
    Seo, Youngho
    Flavell, Robert R.
    Heditsian, Diane
    Brain, Susie
    Esserman, Laura J.
    Joe, Bonnie N.
    Hylton, Nola M.
    Jones, Ella F.
    Ray, Kimberly M.
    RADIOLOGY-IMAGING CANCER, 2024, 6 (02):
  • [47] The Role of Interim 18F-FDG PET/CT in Predicting Early Response to Neoadjuvant Chemotherapy in Breast Cancer
    Pahk, Kisoo
    Rhee, Seunghong
    Cho, Jaehyuk
    Seo, Minhee
    Lee, Sinae
    Park, Taegyu
    Park, Soyeon
    Lee, Eunsub
    Park, Kyung Hwa
    Kim, Chulhan
    Eo, Jae Seon
    Kim, Sungeun
    Choe, Jae Gol
    ANTICANCER RESEARCH, 2014, 34 (08) : 4447 - 4455
  • [48] Tumor metabolism with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer
    Garcia Vicente, Ana Maria
    Soriano, Angel
    Leon Martin, Alberto
    Cruz Mora, Miguel Angel
    Munoz Sanchez, Maria del Mar
    Relea Calatayud, Fernanda
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [49] MRI and 18F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?
    Laura Evangelista
    Domenico Ruggieri
    Luigi Pescarini
    Giorgio Saladini
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1511 - 1514
  • [50] Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer
    Garcia Vicente, Ana Maria
    Cruz Mora, Miguel Angel
    Leon Martin, Antonio Alberto
    Munoz Sanchez, Maria del Mar
    Relea Calatayud, Fernanda
    Van Gomez Lopez, Ober
    Espinosa Aunion, Ruth
    Gonzalez Ageitos, Ana
    Soriano Castrejon, Angel
    TUMOR BIOLOGY, 2014, 35 (11) : 11613 - 11620
12345